STAT3 and neoplasm: STAT3 was also responsible for the modification of TAMs to the tumor supportive M2-like subtype, while the administration of the STAT3 inhibitor combined with anti-angiogenic agents explicitly decreased microvascular density and tumor proliferation, with a lower number of p-STAT3 macrophages [79].